 BALA CYNWYD, Pa., Aug. 19, 2021 GLOBE NEWSWIRE -- Larimar Therapeutics, Inc. Larimar Nasdaq: LRMR, a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that David Bettoun, PhD, Vice President Discovery Non-Clinical RD of Larimar, will be giving an oral presentation at the World Orphan Drug Congress USA 2021, taking place on August 25-27 at the Gaylord National Resort Convention Center in Oxon Hill, Maryland. Details on the presentation, which will feature preclinical in vitro data on Larimars proprietary protein replacement therapy platform, can be found below. 